METHOD AND DEVICE FOR CONTROLLED STIMULATION OF LYMPHATIC FLOW

• US 20080294228A1
• Filed: 05/23/2007
• Published: 11/27/2008
• Est. Priority Date: 05/23/2007
• Status: Abandoned Application

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers
• Inventors: Sweeney, Robert J., Sathaye, Alok S., Shuros, Allan C., Brooke, M. Jason
• Application Number:
  US11/752,377
• Publication Number:
  US 20080294228A1
• Time in Patent Office: Days
• US Class Current: 607/116
• CPC Class Codes: A61N 1/05 for implantation or insertion into the body, e.g. heart electrode A61N1/06 takes precedence
• CPC Class Codes: A61N 1/08 Arrangements or circuits for monitoring, protecting, controlling or indicating for external stimulators A61N1/3603; for implantable neurostimulators A61N1/36128; for heart stimulators A61N1/37; for defibrillators A61N1/3925
• CPC Class Codes: A61N 1/326 for promoting growth of cells, e.g. bone cells
• CPC Class Codes: A61N 1/36007 of urogenital or gastrointestinal organs, e.g. for incontinence control

Abstract

A device and method for controllably augmenting the flow of lymphatic fluid through one or more lymphatic vessels. The device may utilize various means of modulating the flow of lymph, including neural, mechanical and/or chemical stimulation and could be a stand-alone device or be incorporated into any cardiac, neuromodulation and/or drug delivery device.

Claims

1. A device, comprising:

an implantable housing;

monitoring circuitry contained within an implantable housing;

a lymphatic sensor interfaced to the monitoring circuitry for sensing a parameter related to fluid flow within a lymphatic vessel and generating a flow signal therefrom;

a controller interfaced to the monitoring circuitry for processing flow signals generated by the lymphatic sensor; and

,

a lymphatic flow stimulator interfaced to the controller, wherein the controller is programmed to actuate the flow lymphatic flow stimulator in response to changes in the flow signal.

2. The device of claim 1 wherein the lymphatic sensor is incorporated in a lead connected to the monitoring circuitry, the lead being adapted for implantation into or near a lymphatic vessel.

3. The device of claim 1 further comprising a telemetry transceiver and wherein the lymphatic sensor is adapted for implantation into or near a lymphatic vessel and communicates with the monitoring circuitry via wireless telemetry.

4. The device of claim 3 wherein the lymphatic sensor is incorporated into a stent adapted for implantation within a lymphatic vessel or a blood vessel.

5. The device of claim 1 wherein the lymphatic sensor is a sensor of a type selected from a group that includes pressure sensor, an ultrasonic flow sensor, a mechanical flow sensor, inductive flow sensor, and a chemo-sensor for generating a voltage proportional to the concentration of a particular chemical species in the lymphatic fluid.

6. The device of claim 1 further comprising a telemetry transceiver interfaced to the controller for enabling wireless communication with the controller and wherein the controller is programmed to transmit an alarm message via the telemetry transceiver if the flow signal generated by the lymphatic sensor exhibits a specified change.

7. The device of claim 1 wherein the lymphatic flow stimulator comprises a lead having one or more stimulation electrodes incorporated therein adapted for disposition near smooth muscle of the lymphatic vessel or nerves innervating the smooth muscle.

8. The device of claim 1 further comprising:

a drug reservoir and a pumping mechanism interfaced to the controller within the implantable housing; and

,

wherein the lymphatic flow stimulator comprises a drug delivery catheter connected to the pumping mechanism, the drug delivery catheter adapted for disposition near smooth muscle of the lymphatic vessel or nerves innervating the smooth muscle to deliver one or more chemical agents thereto, wherein the one or more chemical agents are selected from a group that includes vessel dilating agents and vessel constricting agents.

9. The device of claim 1 wherein the lymphatic flow stimulator is a mechanical stimulator for causing contraction of lymphatic vessel smooth muscle.

10. The device of claim 9 wherein the lymphatic flow stimulator is a balloon catheter connected to a balloon actuator within the implantable housing.

11. A method, comprising:

implanting a housing having monitoring circuitry and a controller contained therewithin;

implanting a lymphatic sensor interfaced to the monitoring circuitry for sensing a parameter related to fluid flow within a lymphatic vessel and generating a flow signal therefrom;

implanting a lymphatic flow stimulator interfaced to the controller,

programming the controller to actuate the flow lymphatic flow stimulator in response to changes in the flow signal.

12. The method of claim 11 wherein the lymphatic sensor is incorporated in a lead connected to the monitoring circuitry, the lead being implanted into or near a lymphatic vessel.

13. The method of claim 11 wherein the lymphatic sensor is implanted into or near a lymphatic vessel and communicates with the monitoring circuitry via wireless telemetry.

14. The method of claim 13 wherein the lymphatic sensor is incorporated into a stent and implanted within a lymphatic vessel or a blood vessel.

15. The method of claim 11 wherein the lymphatic sensor is a sensor of a type selected from a group that includes pressure sensor, an ultrasonic flow sensor, a mechanical flow sensor, inductive flow sensor, and a chemo-sensor for generating a voltage proportional to the concentration of a particular chemical species in the lymphatic fluid.

16. The method of claim 11 further comprising programming the controller to transmit an alarm message via a telemetry transceiver if the flow signal generated by the lymphatic sensor exhibits a specified change.

17. The method of claim 11 wherein the lymphatic flow stimulator comprises a lead having one or more stimulation electrodes incorporated therein and further comprising disposing the lymphatic flow stimulator near smooth muscle of the lymphatic vessel or nerves innervating the smooth muscle.

18. The method of claim 11 wherein the lymphatic flow stimulator comprises a drug delivery catheter connected to a pumping mechanism and further comprising disposing the drug delivery catheter near smooth muscle of the lymphatic vessel or nerves innervating the smooth muscle to deliver one or more chemical agents thereto, wherein the one or more chemical agents are selected from a group that includes vessel dilating agents and vessel constricting agents.

19. The method of claim 11 wherein the lymphatic flow stimulator is a mechanical stimulator for causing contraction of lymphatic vessel smooth muscle.

20. The method of claim 19 wherein the lymphatic flow stimulator is a balloon catheter connected to a balloon actuator within the implantable housing.